CoChat

Protein Kinase A Effects of an Expressed PRKAR1A Mutation Associated with Aggressive Tumors

Open access
Meoli, Elise, Bossis, Ioannis, Cazabat, Laure, Mavrakis, Manos, Horvath, Anelia, Stergiopoulos, Sotiris, Shiferaw, Miriam L., Fumey, Glawdys, Perlemoine, Karine, Muchow, Michael, Robinson-White, Audrey, Weinberg, Frank, Nesterova, Maria, Patronas, Yianna, Groussin, Lionel, Bertherat, Jérôme, Stratakis, Constantine A. · 2008 · Cancer Research
Cited by 61

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Most PRKAR1A tumorigenic mutations lead to nonsense mRNA that is decayed; tumor formation has been associated with an increase in type II protein kinase A (PKA) subunits. The IVS6+1G>T PRKAR1A mutation leads to a protein lacking exon 6 sequences [R1αΔ184-236 (R1αΔ6)]. We compared in vitro R1αΔ6 with wild-type (wt) R1α. We assessed PKA activity and subunit expression, phosphorylation of target molecules, and properties of wt-R1α and mutant (mt) R1α; we observed by confocal microscopy R1α tagged with green fluorescent protein and its interactions with Cerulean-tagged catalytic subunit (Cα). Introduction of the R1αΔ6 led to aberrant cellular morphology and higher PKA activity but no increase in type II PKA subunits. There was diffuse, cytoplasmic localization of R1α protein in wt-R1α– and R1αΔ6-transfected cells but the former also exhibited discrete aggregates of R1α that bound Cα; these were absent in R1αΔ6-transfected cells and did not bind Cα at baseline or in response to cyclic AMP. Other changes induced by R1αΔ6 included decreased nuclear Cα. We conclude that R1αΔ6 leads to increased PKA activity through the mt-R1α decreased binding to Cα and does not involve changes in other PKA subunits, suggesting that a switch to type II PKA activity is not necessary for increased kinase activity or tumorigenesis. [Cancer Res 2008;68(9):3133–41]

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-08-0064

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 61

Metadata

Authors
Meoli, E., Bossis, I., Cazabat, L., Mavrakis, M., Horvath, A., Stergiopoulos, S., Shiferaw, M. L., Fumey, G., Perlemoine, K., Muchow, M., Robinson-White, A., Weinberg, F., Nesterova, M., Patronas, Y., Groussin, L., Bertherat, J., & Stratakis, C. A.
Venue
Cancer Research
Published
2008-05-01
Volume
68
Issue
9
Pages
3133-3141
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2144693844
Cited by
61
References
2
FWCI
2.11
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Protein Kinase A Effects of an Expressed PRKAR1A Mutation Associated with Aggressive Tumors. https://app.cochat.ai/papers/10.1158/0008-5472.can-08-0064
The paper
Meoli, E., Bossis, I., Cazabat, L., Mavrakis, M., Horvath, A., Stergiopoulos, S., Shiferaw, M. L., Fumey, G., Perlemoine, K., Muchow, M., Robinson-White, A., Weinberg, F., Nesterova, M., Patronas, Y., Groussin, L., Bertherat, J., & Stratakis, C. A. (2008). Protein Kinase A Effects of an Expressed PRKAR1A Mutation Associated with Aggressive Tumors. Cancer Research. https://doi.org/10.1158/0008-5472.can-08-0064

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.